Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-14T17:57:44.749Z Has data issue: false hasContentIssue false
  • English
  • Français

Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post–acute-care setting

Published online by Cambridge University Press:  28 July 2022

Helen L. Zhang Open the ORCID record for Helen L. Zhang [Opens in a new window] ,
Kyle J. Gontjes Open the ORCID record for Kyle J. Gontjes [Opens in a new window] ,
Jennifer H. Han Open the ORCID record for Jennifer H. Han [Opens in a new window] ,
Kevin Alby ,
Zena Lapp Open the ORCID record for Zena Lapp [Opens in a new window] ,
Evan Snitkin ,
Ellie J.C. Goldstein ,
Sean Muldoon ,
Pam Tolomeo  and
Ebbing Lautenbach
Helen L. Zhang*
Affiliation:
Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Kyle J. Gontjes
Affiliation:
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan
Jennifer H. Han
Affiliation:
Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania
Kevin Alby
Affiliation:
Department of Pathology and Lab Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Zena Lapp
Affiliation:
Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan
Evan Snitkin
Affiliation:
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan
Ellie J.C. Goldstein
Affiliation:
R.M. Alden Research Laboratory, Santa Monica, California Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California
Sean Muldoon
Affiliation:
ScionHealth, Louisville, Kentucky
Pam Tolomeo
Affiliation:
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania
Ebbing Lautenbach
Affiliation:
Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Pennsylvania
*
Author for correspondence: Helen L. Zhang, E-mail: helen.zhang1@pennmedicine.upenn.edu. Or Ebbing Lautenbach, E-mail: ebbing@pennmedicine.upenn.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed among 9.9% and 9.1% of isolates, respectively. Nonsusceptibility to ceftazidime-avibactam (1.1%) and plazomicin (0.8%) were uncommon.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 7 , July 2023 , pp. 1159 - 1162
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Martin, A, Fahrbach, K, Zhao, Q, Lodise, T. Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to Enterobacteriaceae: results of a systematic literature review and meta-analysis. Open Forum Infect Dis 2018;5:ofy150.CrossRefGoogle ScholarPubMed
Marquez, P, Terashita, D, Dassey, D, Mascola, L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013;34:144–150.CrossRefGoogle ScholarPubMed
National Center for Emerging and Zoonotic Infectious Diseases. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE), November 2015 update—CRE toolkit. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/pdfs/cre/cre-guidance-508.pdf. Published Novemebr 2015. Accessed July 15, 2022.Google Scholar
Han, JH, Lapp, Z, Bushman, F, et al. Whole-genome sequencing to identify drivers of carbapenem-resistant Klebsiella pneumoniae transmission within and between regional long-term acute-care hospitals. Antimicrob Agents Chemother 2019;63.Google ScholarPubMed
Matuschek, E, Ahman, J, Webster, C, Kahlmeter, G. Antimicrobial susceptibility testing of colistin—evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect 2018;24:865–870.CrossRefGoogle ScholarPubMed
Jones, RN, Holliday, NM, Krause, KM. Validation of Sensititre dry-form broth microdilution panels for susceptibility testing of ceftazidime-avibactam, a broad-spectrum β-lactamase inhibitor combination. Antimicrob Agents Chemother 2015;59:5036–5039.CrossRefGoogle ScholarPubMed
Performance Standards for Antimicrobial Susceptibility Testing, 28th edition. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.Google Scholar
Antibacterial susceptibility test interpretive criteria. US Food & Drug Administration website. https://www.fda.gov/drugs/development-resources/antibacterial-susceptibility-test-interpretive-criteria. Accessed January 14, 2022.Google Scholar
Lapp, Z, Han, JH, Wiens, J, Goldstein, EJC, Lautenbach, E, Snitkin, ES. Patient and microbial genomic factors associated with carbapenem-resistant Klebsiella pneumoniae extraintestinal colonization and infection. mSystems 2021;6:e00177–21.CrossRefGoogle ScholarPubMed
Yu, G, Smith, D, Zhu, H, Guan, Y, TTY L. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol 2017;8:28–36.CrossRefGoogle Scholar
Revell, LJ. phytools: an R package for phylogenetic comparative biology (and other things). Methods Ecol Evol 2012;3:217–223.CrossRefGoogle Scholar
Wilke, C, Wickham, H, Wilke, M. Package ‘cowplot.’ Streamlined plot theme and plot annotations for ‘ggplot2. Cowplot website. https://wilkelab.org/cowplot/. Published 2019. Accessed July 14, 2022.Google Scholar
Lam, MMC, Wick, RR, Watts, SC, Cerdeira, LT, Wyres, KL, Holt, KE. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun 2021;12:4188.CrossRefGoogle ScholarPubMed
Hackel, MA, Lomovskaya, O, Dudley, MN, Karlowsky, JA, Sahm, DF. In vitro activity of meropenem-vaborbactam against clinical isolates of KPC-Positive Enterobacteriaceae. Antimicrob Agents Chemother 2018;62:e01904–17.CrossRefGoogle ScholarPubMed
Supplementary material: PDF

Zhang et al. supplementary material

Table S1 and Figures S1-S3
Download Zhang et al. supplementary material(PDF)
PDF 355.8 KB